Implementing a PROACTive Care Pathway to Empower and Support Survivors of Breast Cancer

Author:

Franzoi Maria Alice1ORCID,Degousée Lena2,Martin Elise13ORCID,Semedo Patricia Miguel4ORCID,Aupomerol Marion2ORCID,Soldato Davide1ORCID,Di Meglio Antonio1ORCID,Chiodi Camila1,Barbier Aude1,Chaouachi Hajer5,Renvoisé Nathalie5,Boinon Diane5ORCID,Fasse Léonor5,Ribeiro Joana2ORCID,Le-Provost Jean Bernard5,Arvis Johanna1,Lazorthes Céline6,di Palma Mario5ORCID,de Jesus Anne7,Raynard Bruno5,Pagès Arnaud8ORCID,Delaloge Suzette2ORCID,Pistilli Barbara2ORCID,Scotté Florian5,Vaz-Luis Ines125ORCID

Affiliation:

1. Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France

2. Breast Oncology Unit, Gustave Roussy, Villejuif, France

3. CNRS—UAR3683 MSH Paris-Saclay, Gif sur Yvette, France

4. Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal

5. Supportive Care and Patient Pathway Department, Gustave Roussy, Villejuif, France

6. Resilience Care, Paris, France

7. Patient Committee, Gustave Roussy, Villejuif, France

8. Biostatistics and Epidemiology Department, Gustave Roussy, Villejuif, France

Abstract

PURPOSE Optimal comprehensive survivorship care is insufficiently delivered. To increase patient empowerment and maximize the uptake of multidisciplinary supportive care strategies to serve all survivorship needs, we implemented a proactive survivorship care pathway for patients with early breast cancer at the end of primary treatment phase. METHODS Pathway components included (1) a personalized survivorship care plan (SCP), (2) face-to-face survivorship education seminars and personalized consultation for supportive care referrals (Transition Day), (3) a mobile app delivering personalized education and self-management advice, and (4) decision aids for physicians focused on supportive care needs. A mixed-methods process evaluation was performed according to the Reach, Effectiveness, Adoption, Implementation and Maintenance framework including administrative data review, pathway experience survey (patient, physician, and organization), and focus group. The primary objective was patient-perceived satisfaction with the pathway (predefined progression criteria for pathway continuation ≥70%). RESULTS Over 6 months, 321 patients were eligible for the pathway and received a SCP and 98 (30%) attended the Transition Day. Among 126 patients surveyed, 77 (66.1%) responded. 70.1% received the SCP, 51.9% attended the Transition Day, and 59.7% accessed the mobile app. 96.1% of patients were very or completely satisfied with the overall pathway, whereas perceived usefulness was 64.8% for the SCP, 90% for the Transition Day, and 65.2% for the mobile app. Pathway implementation seemed to be positively experienced by physicians and the organization. CONCLUSION Patients were satisfied with a proactive survivorship care pathway, and the majority reported that its components were useful in supporting their needs. This study can inform the implementation of survivorship care pathways in other centers.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Oncology (nursing),Health Policy,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3